A stability indicating method development and validation for separation of process related impurities and characterization of unknown impurities of tyrosine kinase inhibitor Nilotinib by RP-HPLC, NMR spectroscopy and ESI-MS
2021 ◽
Vol 12
(4)
◽
pp. 30
2018 ◽
Vol 8
(2)
◽
pp. 196-203
2022 ◽
Vol 10
(01)
◽
pp. 113-120
2015 ◽
Vol 31
(4)
◽
pp. 2499-2505
◽
2012 ◽
Vol 03
(08)
◽
2021 ◽
Vol 14
(3)
◽
pp. 1549-1554
2021 ◽
Vol 14
(3)
◽
pp. 1385-1389
2013 ◽
Vol 77
◽
pp. 49-54
◽